Pharmacokinetics and safety of indisetron tablets in healthy subjects - Multiple-oral dose study

Japanese Pharmacology and Therapeutics

Volumn 32, Issue 11, 2004, Pages 815-821

  Yamada, Tadashi ^a   Tadokoro, Toyohiro ^a   Nakata, Fumihisa ^a   Yonezawa, Katsunobu ^a  

^a KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 HT 4 receptor antagonist; 5 HT 3 receptor antagonist; Anti emetic agent; Clinical pharmacokinetic study; Indisetron hydrochloride

Indexed keywords

INDISETRON; SEROTONIN 3 ANTAGONIST;

AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; MULTIPLE DRUG DOSE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; SINGLE BLIND PROCEDURE; URINARY EXCRETION; VOLUNTEER;

EID: 21044456799     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)